REPL Competitors & Alternatives
Compare Replimune Group Inc with similar stocks in the same industry
Biotechnology
REPL
Main Stock$12.92
Tradestie Score
44
Market Cap
$328.62M
Analyst Upside
+50.9%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$43.62
|
$1.32B | - | 47 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$7.45
|
$1.29B | - | 47 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$29.03
|
$1.29B | - | 57 | Compare |
|
ARDX
Ardelyx, Inc.
|
$3.58
|
$1.29B | - | 40 | Compare |
|
ZYME
Zymeworks Inc.
|
$26.24
|
$1.28B | - | 37 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$6.07
|
$1.27B | - | 40 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 54 | Compare |
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$7.35
|
$1.22B | - | 44 | Compare |
|
PGEN
Precigen, Inc. Common Stock
|
$6.85
|
$1.18B | - | 42 | Compare |
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$54.32
|
$1.17B | - | 48 | Compare |
More REPL Analysis
Data updated: Sep 12, 2026 | Industry: Biotechnology (SIC 2836)
233 stocks in this industry